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Abstract
The maintenance and expansion of the cells required for formation of tissue-engineered cartilage
has, to date, proven difficult. This is, in part, due to the initial solid phase extracellular matrix
demanded by the cells inhabiting this avascular tissue. Herein, we engineer an innovative
alginate-fibronectin microfluidic-based carrier construct (termed a chondrobag) equipped with
solid phase presentation of growth factors that support skeletal stem cell chondrogenic
differentiation while preserving human articular chondrocyte phenotype. Results demonstrate
biocompatibility, cell viability, proliferation and tissue-specific differentiation for chondrogenic
markers SOX9, COL2A1 and ACAN. Modulation of chondrogenic cell hypertrophy, following
culture within chondrobags loaded with TGF-β1, was confirmed by down-regulation of
hypertrophic genes COL10A1 andMMP13. MicroRNAs involved in the chondrogenesis process,
including miR-140, miR-146b and miR-138 were observed. Results demonstrate the generation of a
novel high-throughput, microfluidic-based, scalable carrier that supports human chondrogenesis
with significant implications therein for cartilage repair-based therapies.
1. Introduction
Cartilage lesions represent an important technical
challenge for tissue engineering given the avascular
nature of this tissue, which often leads to defective
intrinsic healing [1]. Unattended cartilage damage
can result in osteoarthritis (OA), the most prevalent
chronic pathology of joints [1, 2]. Defective articular
cartilage and alterations made to the state of bone at
joint margins for instance, are among a diverse set of
signs and symptoms associated with OA [3]. Chon-
drocytes, derived from the native tissue, have been
examined as an apparent cell source of the formation
of neocartilage.
Over the last decades, interest in stem cells for tis-
sue engineering applications has noticeably increased,
given their capacity for self-renewal andmulti-lineage
differentiation [4]. Chondrocytes or chondroprogen-
itors, derived from stromal progenitors, need to be
guided in the formation of native hyaline cartilage,
to avert dedifferentiation and, critically, to ensure the
generation of pre-eminent tissue reconstruction in
vivo that resembles the complex cellular and extra-
cellular matrix (ECM) make-up in the native tissue.
In addition, the generated tissue must be permissive
to typical load-bearing while providing long-lasting
joint performance [5]. A wealth of literature suggests
micromass or pellet culture models, offer an appro-
priatemethod for generating small-scalemicron sized
tissues of engineered neocartilage in vitro. Further-
more, more advanced cartilage-like tissues exhib-
iting improved mechanical properties have been
© 2020 The Author(s). Published by IOP Publishing Ltd
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made exploiting 3D models for cell proliferation
and differentiation [6]. These systems facilitate inter-
actions between the cell and the requisite cellular
environment/matrix [7]. However, these 3D systems
still display an overall lack of homogeneity in cell
responses related to the necrotic cores [8], that could
be assigned to a list of contributing factors includ-
ing: (i) the non-physiological closely compacted cells
that are formed during initial stages of culture, (ii)
the existence of necrotic cores enclosed by in vitro/ex
vivo cell clusters as a consequence of high cell num-
ber, (iii) sub-standard physiological culture condi-
tions and, (iv) diffusion limitations by uncontrolled
establishment of chemical gradients throughout
samples [9].
Recent studies have explored high throughput
strategies for micro-tissue modeling [10, 11]. Thus,
microfluidics offers significant potential for the
generation of high-throughput cell culture proto-
types, presenting unparalleled spatio-temporal con-
trol on the requisite micro-environmental conditions
[12, 13]. To this objective, we present an experimental
droplet-based microfluidic device for the fabrication
and the culture of 3Dmicromass constructs ofmature
chondrocytes and skeletal stem cells (SSCs) generated
under constant laminar flow, termed ‘chondrobags’.
Chondrobags are highly mono-dispersed, pearl-lace
interlinking hydrogel-based structures with pearl and
lace subunit sizes ranging from 100 and 150 µm.
We note that SSCs are a bone marrow derived mul-
tipotent mesenchymal stromal cell (MSCs) popu-
lation with the established propensity for skeletal
regeneration [14].
It is clear that materials used for cartilage tis-
sue engineering significantly affect the pattern of
the gene expression of the chondrocyte popula-
tion therein [15]. Mimicking the hydrated environ-
ment of native cartilage, hydrogels offer an attract-
ive approach for the development of cartilage regen-
erative strategies. Hydrogels are made by crosslink-
ing naturally derived polymers, such as collagen and
alginate, as well as polymers manufactured, such as
polyethylene glycol and polyacrylamide. These poly-
mer networks are crosslinked hydrophilic systems
that are able to retain high volumes of fluid without
dissolving. This allows construction of a microenvir-
onment for cells, which takes on the appearance of
native tissue through facilitation of waste and nutri-
ents exchange [16]. Furthermore, hydrogels offer a
strategy for the homogeneous encapsulation of cells
of interest in comparison to numerous reported scaf-
folds. Critically, the mechanical properties of hydro-
gels, such as viscoelasticity, typically, can be fine-
tuned to mimic those found in the native cartilage
[17]. Alginate is a biocompatible material that is used
to form microporous hydrogels [18]. The permeable
nature of the alginate hydrogel allows diffusion of
nutrients, molecules and facilitates communication
and contact between cells, providing a rich ECM-like
environment that can support cell viability [19].
Indeed, a number of studies have shown that MSCs-
laden alginate hydrogels can support chondrogenesis
[19–21].
Naturally found alginate polymers offer good
hydrophilicity and allow ionic crosslinking. How-
ever, alginate hydrogels lack intrinsic cell adhesion
domains, which diminish their biological activity
and subsequently hamper their use in tissue engin-
eering [22]. Approaches to overcome this limita-
tion have centred on the incorporation of molecules
such as Arg-Gly-Asp (RGD)-based peptides to facil-
itate integrin binding [16]. The display of an RGD
sequence in alginate hydrogels provides a strategy for
control over the phenotype of participating chon-
drocytes, osteoblasts, and MSCs [23]. The functional
RGD peptide is a cell adhesion motif, found in ECM
proteins including fibronectin (FN) [24] and sug-
gested to positively contribute to the chondrogen-
esis of MSCs, although, the effect is controversial and
dependent on application [25]. FN has been denoted
to initiate the cellular signalling of chondrocyte dif-
ferentiation [26] and is critical in orchestration of the
assembly of further ECM proteins including collagen
[27]. Furthermore, the down-regulation of FN can
alter cell morphology and shape resulting in reduced
chondrogenic differentiation [28].
Cationic molecules such as transforming growth
factor beta (TGF-β) display affinity towards the neg-
atively charged alginate molecules by way of the Cou-
lombic interaction and can be freed from alginate
with slow kinetics [29]. In addition, the 12th–14th
type III repeats of fibronectin (FN III12–14) bind
to the TGF-β superfamily with high affinity [30].
The TGF-β superfamily is made up of three type
of isoforms (TGF-β1, TGF-β2, and TGF-β3); how-
ever, exclusively, TGF-β1 and TGF-β3 are relevant
for stem cell chondrogenic differentiation [31, 32].
TGF-β3 displays a higher chondrogenic promise as
compared to TGF-β1, leading to enhanced differen-
tiation [33]. However, it remains unclear, if this TGF-
β3 enhanced differentiation is correlated with higher
responsiveness for chondrocyte hypertrophy.
We have generated an innovative alginate-FN
micron-sized subunit carrier for chondrogenesis—
chondrobags. This novel system allows high-
throughput fabrication of reproducible microgels
with precise control over the density of embed-
ded cells, shape and mono-dispersity. The chon-
drobags incorporate FN to immobilise growth factors
and encapsulated cells while bypassing the diffu-
sion limit for oxygen and nutrition given the chon-
drobag size. In addition, using pearl-lace interlinking
hydrogel-based structures, chondrobags can be used
for alternative microfluidic-based bioprinting [34].
The alginate-FN chondrobags presenting TGF-β1
in solid phase provide a favourable chondrogenic
microenvironment for specific differentiation of in
situ cultured skeletal stem cells (SSCs) and human
2
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articular chondrocytes (HACs), with implications
therein for future tissue engineering applications.
2. Materials andmethods
2.1. Human bonemarrow derived SSCs isolation
and culture
Bone marrow was sourced from a patient undertak-
ing total hip replacement surgery at Spire Hospital in
conjunctionwith the full ethical consent and approval
from the hospital ethics committee (LREC 194/99/w,
27/10/10), through which informed patient consent
was attained. All procedures making use of human
tissue and cells were carried out in agreement with
stipulated recommendations and regulations. Bone
marrow (male 70 years of age) was acquired and
used for isolating and culturing human bone mar-
row derived SSCs as previously detailed [35]. Washed
bone marrow mixture was sieved through a 70 µm
cell filter and separated using Lymphoprep™ (Lonza).
Prior to a wash step with magnetic activated cell sort-
ing (MACS) buffer (BSA and EDTA in PBS), har-
vested mononuclear cells were incubated in block-
ing buffer (α-MEM, 10% human serum, 5% fetal calf
serum (FCS) and 10 mg ml−1 bovine serum albu-
min). Cells were incubated in 1 ml of hybridoma-
based STRO-1 antibody and following a wash with
MACS buffer were re-suspended in 1 ml containing
800 µl MACs buffer and 200 µl rat anti-mouse IgM
microbeads (Miltenyi Biotec Ltd). A second MACS
harvest for target cells was followed by washing with
MACS buffer. Isolated target cells were washed and
re-suspended in α-MEM containing 10% FCS and
1% penicillin/streptomycin (P/S) and cultured in
tissue culture flasks.
2.2. Human articular chondrocytes isolation and
culture
Femoral head was acquired from a male patient
(61 years of age) undergoing total hip replacement
surgery at Southampton General Hospital, in con-
junction with the full ethical consent and approval
from the hospital ethics committee (LREC 194/99/w,
27/10/10), with informed patient consent attained.
The OA femoral head was classified as end stage
OA (3–5 OARSI). The articular cartilage was dis-
sected from the femoral head and sliced into small
sections within 6 h post-surgery. Cartilage sections
were incubated for 30 min at 37 ◦C in 10% tryp-
sin (Sigma Aldrich) followed by 15 min in 0.1% hya-
luronidase (Sigma Aldrich) following a wash with
PBS. This trypsin-hyaluronidase step was followed
by a further wash and incubation for 12–15 h at
37 ◦C in 1% collagenase B (Roche Diagnostics). The
suspension containing the digested articular chon-
drocytes was filtered through a 70 µm filter. Isol-
ated chondrocytes were re-suspended in DMEM/F12
containing 5% FCS, 1% insulin-transferrin-selenium
(ITS) (Sigma-Aldrich), 1% P/S and 0.2% of ascorbic
acid (Sigma-Aldrich), and placed into tissue culture
flasks.
2.3. Microfluidic fabrication
Co-flow focusing glass capillary device (figures 1(A)
and (B)) for pearl-lace like microgel production
developed in this study, was first reported by Witte
et al [34]. Glass capillaries (<1.8 mm, TST150-6 and
TW100-6, World precision instruments, Inc.) were
tapered to desired hole sizes (0.04–0.07 mm) using
a micropipette puller (P-97, Sutter Instruments) and
centrally aligned in a square capillary of 2 mm
ID (World precision instruments, Inc.). Sigmacote
(Sigma-Aldrich) was used to modify the glass surface
generating a hydrophobic layer. Capillaries were fixed
on a cover-slide and using soft tubing, coupled with
controllable syringe pumps (Harvard Apparatus).
2.4. Cell encapsulation
Both SSCs and HACs populations were initially
treated for 40 min with collagenase IV (200 µg ml−1)
in α-MEM prior to detachment from culture plates
using 0.025% (w/v) Trypsin–EDTA with 0.05% gluc-
ose for 10min at 37 ◦C. To prepare a 2% alginatemix-
ture, both cell types were individually re-suspended
in the corresponding basal media and subsequently
mixed 1:1 together with a medium viscosity 4% (w/v)
sodium alginate (Sigma-Aldrich, UK) solution. FN
sourced from human plasma (Sigma) was added to
the mixture to give a final concentration 20 µg ml−1.
The water-based alginic cell mixture entered the
microfluidic device through one of the two chan-
nels of a theta-shaped capillary, while leaving the
other channel for 200 mM calcium chloride aqueous
solution. Mineral oil (Sigma-Aldrich, UK) with 2%
Span 80 (Sigma-Aldrich, UK) was introduced as the
continuous phase through a square-shaped housing
capillary for dispersing the two water-based solutions
as they mixed within the flow focusing regime. Pre-
warmedbasal culturemediawas used as the collection
solution for formed hydrogels. This step was fol-
lowed by a 100mM calcium chloride wash before cul-
turing in either basal media or chondrogenic media
comprising 10 nM dexamethasone, 100 µM ascor-
bic acid, 10 µg ml−1 ITS and 10 ng ml−1 of either
TGF-β1 or TGF-β3 (Peprotech) at 37 ◦C and 5%
CO2 in a humidified atmosphere. Media (chondro-
genic differentiation media and basal media) was
changed every 2 days until the end of the experiment
at day 28.
2.5. Viability assay
Viability studies were carried out following incuba-
tion of the cell-laden hydrogels for an hour at 37 ◦C in
a 100mM calcium chloride solution containing 2 µM
calcein and 2 µM ethidium homodimer-1 (EthD-1)
(Viability/Cytotoxicity Kit, Life Technologies, UK).
For the viability calculation, the total number of live
cells (stained green) were analysed in comparison to
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Figure 1. Droplet-based microfluidic setup, mono-dispersity and encapsulation. (A) Schematic representation of the microfluidic
device and encapsulation of eukaryotic cells. (B) Image of the capillary based microfluidic device. (C) A snapshot of
encapsulation of cells using the microfluidic device. Scale bar: 100 µm. HACs: human articular chondrocytes, SSCs: Stro-1
enriched skeletal stem cells.
the total number of cells (stained either green or red).
Viability was expressed as a percentage of the con-
trol. The hardware and software from EVOS Fl Col-
our Cell Imaging System were used for assigning the
stained samples (green for live and red for dead cells).
For measuring the pixel intensity of the fluorescence
signals, sample images were processed using ImageJ
software version 1.51 (100) and later graphed using
GraphPad Prism (version 8.0 software).
2.6. RNA isolation and quantification
Chondrobags were prepared with a PBS wash at the
end of the culturing period, prior to a 10 min incub-
ation at 37 ◦C incubation with 1 ml of dissolving
buffer (0.055 M sodium citrate, in 0.03 M EDTA,
0.15 M NaCl, pH 6.8) at 1000 rpm. This step was fol-
lowed by centrifugation at 10 000 rpm for 2 minutes,
a PBS wash and another round of centrifugation at
14 500 rpm for two minutes. 350 ml of RLT Plus Buf-
fer was used to lyse the pellets formed by the cells.
The lysed cell mixture was added to 540 ml RNA-
free water and 10 ml Protease K solution (Qiagen)
and further incubated for 10 min at 1000 rpm, 55 ◦C.
AllPrep DNA/RNA/miRNA Universal Kit (Qiagen)
was used to isolate RNA from the samples following
the guidelines by the manufacturer. Extracted RNA
samples were quantified using a Nanodrop ND-1000
spectrophotometer.
2.7. cDNA synthesis andmRNA expression analysis
cDNA synthesis and real time quantitative PCR
(qPCR) were carried out to analyse expression of
mRNA in human SSCs andHACs. SuperScript® VILO
cDNA Synthesis kit from Applied Biosystems was
used for the synthesis of cDNA from sample contain-
ing isolated RNA. In brief, RNA was mixed with 2 µl
5X VILO™ reaction mix and 1 µl 10X SuperScript®
enzyme. The mixture was subsequently incubated for
10 min at 25 ◦C and, thereafter, by a further incub-
ation at 42 ◦C for 2 h and 85 ◦C for 5 min. qPCR
was carried out with 10 µl of GoTaqmaster mix (Pro-
mega), 5 µl of upH2O and 2 µl of reverse primer
and 2 µl of forward primer for the gene of interest
(primers listed in table S1) and 1 µl of sample con-
taining isolated RNA. A 96 well-plate with each well
containing a final mixture of 20 µl was later ana-
lysed using Applied Biosystems, 7500 Real Time PCR
system. Acquired data was analysed using version
2.0.5 program of Applied Biosystems 7500 System
SDS. To identify the most stable housekeeping genes,
standard optimisation procedures were performed.
For normalising Ct (cross-over threshold) values for
SSCs experiments, ACTB as the endogenous house-
keeping gene and for HACs analysis, GAPDH were
used respectively. The fold expression levels were cal-
culated using delta-delta Ct method for each tar-
get gene. All the sample readouts as well as con-
trol (negative control with no cDNA) were analysed
from triplicates.
2.8. miRNA expression analysis
RNA extracted as detailed in RNA isolation and
quantification were assessed for expression of: miR-
140, miR-146b or miR-138 using TaqMan® MiRNA
Assays (Table S2). Every individual assay contained
two primers: one primer was used for cDNA syn-
thesis and the second primer was used to perform
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TaqManq-PCR. For generating cDNA specific to each
individual assay, specific miRNA from total RNA was
generated with TaqMan® MiRNA Reverse Transcrip-
tion Kit using a modified protocol from the manu-
facturer. In brief, a reaction mixture containing of
3.58 µl upH2O, 0.75 µl 10X Buffer, 1.88 µl of RNase
inhibitor, 1.50 µl of RT primer, 0.08 µl of dNTPs and
10 ng of total RNA was made and incubated at 16 ◦C
for 30 min followed by 30 min at 42 ◦C and further
5 min of incubation at 85 ◦C before termination at
42 ◦C. qPCR was carried out with 5 µl of TaqMan®
Universal PCRMasterMix containingNoAmpErase®
UNG fromLife technologies. The qPCR also included
3.34 µl of upH2O, 0.5 µl of TM primer and 0.8 µl of
cDNA. A 96 well-plate containing this mixture was
assessed using Applied Biosystems, 7500 Real Time
PCR system and data gathered analysed using version
2.0.5 program from Applied Biosystems 7500 System
SDS. Standard optimisation procedures were per-
formed to determine the appropriate housekeeping
gene for the study of miRNA expression. For norm-
alising Ct values, RNU44, was used as a housekeep-
ing control RNA for miRNA. To calculate the fold
expression level of each gene of interest, delta-delta Ct
method was employed. All sample readouts, includ-
ing negative controls (no cDNA), were analysed from
duplicates.
2.9. Enzyme linked immunosorbent assay (ELISA)
Solid Phase Sandwich ELISA for transforming
Growth Factor Beta 1 and 3 release from the algin-
ate construct were measured using Human TGF-
β1 DuoSet ELISA (DY240-05) and Human TGF-
β3 DuoSet ELISA (DY243) kits from R&D systems.
0.5 ml of alginate micro-beads (with and without FN
at 20 µg ml−1 concentration) were soaked in 5 ml
DMEM media containing either TGF-β1 or TGF-β3
at the concentration of 10 ngml−1 overnight. The fol-
lowing day, micro-beads were placed into freshmedia
and samples for ELISAwere taken at 1.5, 3, 6 and 24 h.
ELISA steps were carried out according to manufac-
turer’s instructions and the readouts performed using
BioTek™ Synergy™ HT Multi-Detection Microplate
Reader.
2.10. Histology
Chondrobags were washed in 0.1 mM calcium chlor-
ide and fixed in 10%buffered formalin (neutral) prior
to histological analysis. Specimens were dried using a
series of graded ethanols, embedded in OCT (Cell-
Path, UK) and cryo-sectioned at 5 µm thickness.
Dehydrated sections were collected onto APEs coated
slides, air dried for 30 min and stored at−20 ◦C until
required for staining. For histological evaluation, sec-
tions were warmed at 37 ◦C for 30 min and washed
in RO water prior to staining with Alcian Blue/Sirius
Red and Safranin O/Fast Green. Briefly, sections were
stained with Weigert’s haematoxylin (A and B, 1:1
mix, Clin-Tech, UK) for 10 min prior to staining
with 0.5% Alcian Blue (Sigma, UK) for 10 min, fol-
lowed with molybdophosphoric acid (Sigma, UK)
for 10 min and finally with Sirius Red (Clin-Tech,
UK) for an hour or were stained with Fast Green
(FCF) solution for 5 min followed with Safranin O
for 5 min. Between each staining step, slides were
rinsed in a water bath for 1 min and drained. Slides
were finally dehydrated through increasing ethanol
concentrations and cleared in Histoclear (50%, 90%,
100%-1, 100%-2 ethanol and Histoclear-1 and 2 each
for 30 s) before being mounted in p-xylene bis-
pyridinium bromide (DPX). Sections were observed
using an Olympus dotSlide Virtual Microscopy Sys-
tem and images processed usingOlympusOlyVIA 2.9
image analysis software.
2.11. Statistical analysis
Data are presented as mean values and standard devi-
ations (SD). Statistical analysis was performed by a
one-way ANOVA, a Tukey post-hoc test and Student’s
t test in GraphPad PrismTM 8 software with a level of
significance of p < 0.1 marked by ∗, p < 0.05 marked
by ∗∗, p < 0.001marked by ∗∗∗ and p< 0.0001marked
by ∗∗∗∗.
3. Results and discussion
3.1. Microfluidic fabrication of mono-dispersed
alginate-fibronectin chondrobags and
encapsulation of SSCs and HACs
SSCs and HACs were encapsulated in pearl-lace
like chondrobags using co-flow focusing
glass capillary devices (figures 1(A)–(C) and
supplementary video 1 and 2 (available online at
https://stacks.iop.org/BF/12/045034/mmedia)). The
design was optimised in respect to our previous
report for encapsulation of a co-culture of MSCs
and engineered bacteria [34].
The alginate-calcium composite is a diffusion-
based hydrogel prepared by ionic cross-linking. Dif-
fusion is a time-dependent process and for this
reason, fully homogeneous hydrogels can never
be fully attained. Nevertheless, as the bead size is
reduced, heterogeneity is reduced between formed
hydrogels. As a consequence, calcium diffusion
occurred rapidly in the micro-sized beads leading to
improved and high encapsulation efficiency (>99%)
(figure 2(A)) within each microgel (supplement-
ary Video 2), leading to the generation of repro-
ducible chondrobags (figure 2(B)). The shape and
size of the pearl-lace microgel construct chosen for
this study provided efficient volume ratios between
material and cell, eliminating the diffusion cap of
100 to 200 µm for the transport of oxygen, nutri-
ents including ingress of vital biomolecules for
encapsulated cells and facilitation of removal of
cell waste [36]. Chondrobags were generated at 5–
10 units per second within selected flow rates con-
taining ∼2.6e + 07 cells ml−1 (figures 2(C) and
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Figure 2. Encapsulation efficiency, cell density and volume mono-dispersity of chondrobags. (A) Cell (HACs and SSCs)
encapsulation efficiency. The cell counts at each time point are the result of eight measurements sequentially acquired at 30-min
intervals at room temperature for 2 h. (B) Volume distribution of produced chondrobags of two miscible fluid streams under
laminar flow conditions using flow rates of 125–250 µl h−1 for the two inner phases and 3000 µl h−1 for the outer phase. The
median volume of the formed chondrobag was 0.16 mm3 with a RSD of 3.2%. (C) Cell concentrations used in this study. (D)
Selected flow rates. (E) Cell concentration per chondrobag. (F) A snapshot of chondrobag filled with HAC. Scale bar: 100 µm.
HACs: human articular chondrocytes, SSCs: Stro-1 enriched skeletal stem cells.
(D)). This resulted in cells residing in close prox-
imity (∼103 cells per chondrobag, figure 2(E)) while
facilitating nutrition and waste diffusing through the
porous micro-structures of the alginate-FN hydrogel
(figure 2(F)).
The superiority of 3D over 2D cultures to enhance
stem cells functions are well documented, and the
culture of SSCs in 3D has previously demonstrated
enhanced stromal differentiation along the chon-
drogenic lineage [37]. In contrast to 2D cultures,
the culture of stem cells in 3D promoted enhanced
cell-cell contact; facilitating exposure of cells to sub-
strates with different physical properties including
viscoelasticity and topography together with the dis-
play of assorted endogenous and exogenous ECM
adhesion motifs for integrins [37]. The application
of droplet microfluidics for 3D micromass form-
ation with HACs and SSCs, together with in situ
fine temporal control over the constituents of bio-
materials provided a powerful platform to deliver
reproducible and, crucially, a high-throughput form-
ation of functional micromass constructs [38, 39].
Such a strategy has been undertaken using pluri-
potent stem cells [40–42]. The incorporation of
mechanical stress [43] and hypoxia [44], offer
future approaches to enhance and further mimic the
physiological environment to enhance chondrogenic
differentiation.
It has been shown that a bone-like
physicochemical microenvironment can override
chondroinductive signals including TGF-β1. The
extracellular calcium-sensing receptor (CaSR)
of human BM-derived MSCs has shown to
become hyperstimulated by bone-like biomi-
metic hydroxyapatite (BBHAp) [45]. However,
in this study, the calcium concentration used
to gel the alginic acid was retained at the same
level for all samples including the negative con-
trol constructs while studying the impact of
TGF-β1 and TGF-β3 separately in FN containing
chondrobags.
Studies have established that the permeable
structure of a scaffold can aid cell attachment, prolif-
eration and differentiation, which can lead to gener-
ation of the phenotype of interest in a cell [32, 46].
Chondrobags combine alginate and FN to provide
a cost-effective facile strategy for three-dimensional
construct generation (18–36 k chondrobags per hour)
with a clear potential for cartilage tissue engineer-
ing. Correct porosity provides appropriate shape
and environmental cues through mimicry of the
chondrocyte lacunae to facilitate proliferation and
differentiation. The favourable porosity, thin walls
and excellent interconnectivity between pores of the
hydrogel, contribute to nutrient and metabolic waste
exchange. The induced condensation of HACS and
SSCs in chondrobags is a significant milestone in
comparison to current conventional scaffold-free sys-
tems requiring 3D culture, predominantly based on
micromass pellets derived using centrifugation [8].
The use of centrifugation, as an initial step, typic-
ally generates restrictive cell to cell and cell to ECM
interactions, resulting in high variability in the time
required to form 3D aggregates [9]. In addition,
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traditional macro-pellet models are often too large
and, typically, suffer from heterogeneity of cell phen-
otype and the formation of necrotic cores [8, 47]. As
shown in Supplementary Video 3, pearl-on-thread
chondrobags can be used as a low-cost cell-laden
bioprinting alternative.
3.2. Skeletal cell viability, cell cluster and
micro-mass formation in chondrobags
The advantages of reduced shear stress experienced
during cell encapsulation in chondrobags due to the
channel design and low flow rates of this micro-
fluidic design [34], contributed to high cell viabil-
ity observed throughout the hydrogel. Evaluation of
the cell viability of HACs and SSCs demonstrated
the presence of live cells (>90%) with negligible
necrotic cells present in the central regions of cell
clusters in the chondrobags. Viability and biocom-
patibility of alginate-FN chondrobags was confirmed
1, 3 and 24 h following encapsulation and, cru-
cially, at the conclusion of the studies, on day 28.
Figures 3(A)–(D) demonstrate the level of viabil-
ity observed following encapsulation at day 0 and
at 28 d. For HACs, no differences in cell viability
were observed between cells cultured in chondrogenic
media with TGF-β1 or TGF-β3 (figures 3(A) and
(B)). Enhanced HACs cell numbers were observed
within chondrobags loaded with TGF-β3 with an
average of 11.8 cells per cluster, as compared to 8.3
cells per cluster in TGF-β1 and 1.8 cells per cluster
for control samples (figure 3(H)). This variation is
likely a consequence of differences in cell prolifera-
tion, given all the samples comprised the same initial
cell density per chondrobag (figure 2(E)). In addi-
tion to higher cell counts per cluster (1.4 times), the
area of clusters in TGF-β3 was almost twice (1.9
times, normalised against area of cell clusters in con-
trol sample) the size as compared to those stimu-
lated with TGF-β1 (figure 3(G)). Interestingly, this
finding is consistent with the cell volume expansion
of hypertrophic chondrocytes in the growth plate,
as a consequence of an increase in organelles and
increased metabolic activity [48]. Mueller and col-
laborators have reported this to be the case for the
enhancement of hypertrophy inMSC chondrogenesis
[49].
SSCs encapsulated within chondrobags displayed
a discrete increase in the numbers of necrotic cells
following stimulation with TGF-β3 and TGF-β1, as
compared to the control samples (figures 3(C) and
(D)). The micromass samples generated by SSCs
within chondrobags, stimulated with TGF-β1 or
TGF-β3, were noted to be more compact with no
clear border (space) between cells within the same
cluster/colony (figures 3(C) and (F)) as compared
to the more dispersed HACs micromass samples
(figures 3(A) and (E)) after 28 d. The slight rise in the
total number of necrotic cells in the centre of SSCs
micromass samples is likely due, in part, to the larger
size of the compact cell masses due to cell prolifer-
ation (7 and 5.1 times larger cluster area, normal-
ised against area of cell clusters, in control sample
for TGF-β1 and TGF-β3, respectively. Figure 3(G))
Hence, hypoxia may have been induced with cells at
the centre of the compact mass potentially deprived
of nutrients/oxygen. These observations are signific-
ant given current literature has evidenced viability but
limited cell proliferation [21].
3.3. Quantification of TGF-β in chondrobags
FN is known to have specific interactions with a
diverse range of GFs, such as PDGF, FGF, IGF, TGF-
β and others [30, 50]. The extent of this interac-
tion varies within members of each superfamily.
Within the TGF-β superfamily, TGF-β1, BMP-2,
and BMP-7 display a high measure of affinity to a
domain containing the 12th to 14th type III copies
of FN (FN III12–14). However, in comparison, TGF-
β2, TGF-β3, BMP-4, and BMP-6 did not exhibit
notable binding to FN [30]. Consistent with this
finding, GF release studies in chondrobags demon-
strated that alginate-FN microgels display a 4-fold
higher affinity for TGF-β1 in comparison to TGF-β3
(figure 4). TGF-β1 was loaded and observed to be
slowly released over 24 h in alginate-FN hydrogels.
In contrast, there was negligible release (and sub-
sequent uptake) of TGF-β1 in alginate-based chon-
drobags, in the absence of FN. The same conditions
examined for TGF-β3 in FN-free chondrobags res-
ulted in no detectable readings (figure 4). TGF-β1
and TGF-β3 interactions with FN result in modu-
lation of their parting from the alginate-FN micro-
gel (solid phase) to the soluble phase, hence reg-
ulating their diffusion, and dissipation concentra-
tion locally and consequently influencing cell sig-
nalling. We showed that higher local concentra-
tions of TGF-β1 in chondrobags are influenced by
the presence of FN. We hypothesise that TGF-β1 is
bound to FN (FNIII12–14) and, given this occurs
adjacent to the integrin binding region (FNIII9-10),
provides the alginate-FN microgels with synergistic
TGF-β1/integrin signalling leading into a highly
permissive chondrogenic microenvironment [51]
(figure 2(F)).
3.4. Quantification of gene expression in HACs and
SSCs cultured chondrobags
qPCR of chondrocyte-related marker transcripts was
used to demonstrate the chondrogenic differenti-
ation of SSCs (figures 5(K)–(T)) and the pheno-
type maintenance of HACs (figures 5(A)–(J)), fol-
lowing encapsulation within engineered alginate-FN
chondrobags, with growth factors bound to FN and
presented from a solid phase. The chondrogenic gene
SOX9 has been observed during the in vitro induction
of chondrogenesis and the subsequent promotion
of the transcription of cartilage proteins, including
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Figure 3. Skeletal cell viability, cell cluster and micro-mass formation in chondrobags. (A) Microscopy images of
alginate-fibronectin (FN) chondrobags containing human articular chondrocytes (HACs) cultured in the presence of TGF-β1 or
TGF-β3 for up to 28 d relative to untreated control. (B) HACs viability graph. (C) Microscopy images of alginate-FN
chondrobags containing Stro-1 enriched skeletal stem cells (SSCs) cultured in the presence of TGF-β1 or TGF-β3 for up to 28 d
relative to untreated control. (D) SSCs viability graph. (E) Microscopy images of alginate-FN chondrobags containing HACs
cultured in the presence of TGF-β1 or TGF-β3 for up to 28 d relative to untreated basal control. Individual cells are highlighted
within a red circle. (F) Microscopy images of alginate-FN chondrobags containing SSCs cultured in the presence of TGF-β1 or
TGF-β3 for up to 28 d relative to untreated basal control. Micro-masses are highlighted within a red circle. (G) Graph with area of
SSCs and HACs cultured in the presence of TGF-β1 or TGF-β3 for up to 28 d relative to untreated basal control. (H) Graph with
number of cells found in clusters containing HACs after 28 d. Cells in green are stained with Calcein AM. Scale bar: 100 µm. The
hydrogel was stained with Viability/Cytotoxicity Kit with viable cells in green (Calcein AM) and non-viable cells in red (Ethidium
homodimer-1). Scale bar: 100 µm. N⩾ 5–10 microgels were analysed for each condition. Additional images can be found in
supplementary figure 1.
type II collagen and aggrecan [52]. Type II colla-
gen (COL2A1) is the predominant collagen present
in physiological hyaline cartilage, providing cartilage
with tensile strength [53]. Aggrecan (ACAN), the
characteristic proteoglycan produced by chondro-
cytes, has been shown to link to collagen fibrils via
hyaluronic acid. Importantly, the polyanionic nature
of aggrecan draws water, which provides for cartil-
age expansion, key to the generation of mechanical
function [54].
Expression of SOX9 (early marker), COL2A1
(mid/latemarker) andACAN confirmed the potential
8
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Figure 4. TGF-β binding affinity for the full-length fibronectin (FN) in chondrobags. Infographic detailing the ELISA sample
preparation. The following samples were collected at 1.5, 3, 6 and 24 h; fibronectin-alginate with and without TGF-β1,
FN-alginate with and without TGF-β3, alginate only with and without TGF-β1 as control, alginate only with and without TGF-β3
as control. (B) Optical density readings of TGF-β1. (C) Optical density readings of TGF-β3. (D) Concentrations were calculated
based on optical density and reconfirmed following GF uptake readings from medias with known GF concentrations. Significant
binding over baseline (binding to BSA, value of 0.1, grey box in B) indicated (n= 6, means± SD). ∗P = 0.001; Student’s t test.
of alginate-FN chondrobags to maintain the chon-
drogenic phenotype of HACs. These markers showed
no significant differences between chondrobags
loaded with either GFs; despite TGF-β3 not being
bound to chondrobags with as high affinity as
TGF-β1 (figure 4). Chondrogenic associated SOX9
expression was observed to be notably up-regulated
in HACs loaded with TGF-β1 (4.1-fold change) and
loaded with TGF-β3 (3.6-fold change) (figure 5(A)).
This was also observed for COL2A1: with TGF-
β1 (111.4-fold change) and treated with TGF-β3
(252.7-fold change) (figure 5(B)), and ACAN: 8.5-
fold change with TGF-β1 and 8.1-fold change treated
with TGF-β3 (figure 5(C)). This cumulative increase
in the expression of COL2A1 and ACAN was in line
with previous studies [22, 55].
In contrast, SSCs did not display a clear and
significant differentiation along the chondrogenic
lineage. However, several studies have identified a
discrete decrease in aggrecan expression for cells cul-
tured within a 3D construct, supporting the cur-
rent findings using SSCs (figure 5(M)). Only SOX9
expression was significantly up-regulated follow-
ing SSCs treatment with TGF-β1 (4.7-fold change)
and treatment with TGF-β3 (4.6-fold change)
(figure 5(K)).
There are a number of markers of hypertrophic
chondrocytes, with collagen type X and MMP13 the
most widely recognised [52, 56]. Type X collagen
functions as a substructure for ensuing matrix calci-
fication [57]. Hypertrophic ECM functionally differs
to physiological hyaline cartilage and, is in part, com-
parable to bone matrix. In this context, the current
studies indicate that following 28 d of chondrogenic
differentiation, HACs in chondrobags with TGF-
β1 bound to FN displayed reduced commitment to
the formation of hypertrophic chondrocytes, com-
pared to cells stimulated with TGF-β3 (figures 5(D)–
(E)). Strikingly, the current results observed using
engineered chondrobags, with TGF-β1 bound to
FN, demonstrate negligible evidence of hypertrophic
chondrocytes, enabling the maintenance of the
required chondrocytic phenotype for cartilage tissue
repair.
Specific genes for proliferation and cell cycle
[58] were also examined. HACs and SSCs encap-
sulation in alginate-FN chondrobags resulted in
modulation of essential components in G1/S,
with decreased levels of p16 (CDKN2A), increased
CDK6 and cyclin expression (CCDN1), resulting
in enhanced cell cycle progression and prolifera-
tion (figures 5(H)–(J) and (R)–(T)). In the cur-
rent study, we observed a significant up-regulation
of MKI67 in cells encapsulated in chondrobags with
TGF-β1 bound to FN (5-fold change for HACs and
35-fold change for SSCs) (figures 5(G) and (Q))
and to TGF-β3 (1.9-fold change for HACs and
1.5-fold change for SSCs) (figures 5(G) and (Q)),
indicating higher proliferative activity of cells within
TGF-β3 alginate-FN chondrobags than cells within
TGF-β1.
TGF-β1 appears to be closely connected with cell
growth and differentiation providing a crucial role
in the regulation of autocrine and paracrine pro-
cesses [59]. In addition, TGF-β1 is a growth modu-
lator with multi-physiological potencies on immune
suppression and inflammation, cell differentiation,
wound healing and cancer [60]. However, Mueller
and colleagues failed to detect any differences between
aggregates preconditioned with TGF-β1 and TGF-
β3 following histological evaluation and quantific-
ation of alkaline phosphatase (ALP) secretion [49].
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Figure 5. Gene expression in HACs and SSCs cultured within chondrobags. Chondrogenic, hypertrophic, proliferation and cell
cycle specific gene expression in primary human articular chondrocytes (HACs) (A)–(J) and primary human skeletal stem cells
(SSCs) (K)–(T) cultured in the presence of TGF-β1 or TGF-β3 for up to 28 d relative to untreated control. Differential expression
of A-K: SOX9, B-L: COL2A1, C-M: ACAN, D-N: COL10A1, E-O:MMP13, F-P: PCNA, G-Q:MKI67, H-R: CCDN1, I-S: CDK6,
J-T: CDKN2A analysed by qPCR. Values is the mean± SD of triplicate determinations per sample. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, one-way ANOVA.
The likely differences from our study reside with
the observation that in the engineered chondrobags,
TGF-β1 is also bound to FN and presented from a
solid phase (figure 4), with TGF-β1 more accessible
to the encapsulated cells and thus favouring chondro-
genic differentiation.
3.5. microRNA profiling in HACs and SSCs
cultured in chondrobags
Small noncoding RNAs (19–24 nucleotides long)
have gained significant research interest in recent
years [61]. MicroRNAs (miRNAs) in particular
are important regulators of gene expression [62].
miRNAs are involved in the process of stem cell dif-
ferentiation, together with stem cell therapy and can
prompt skeletal regeneration and thus, miRNAs offer
innovative approaches to prevent/treat OA and osteo-
porosis (OP) [63]. Following culture of HACs and
SSCs with or without TGF- β1 or TGF- β3 for 28 d,
TaqMan qPCR was used to determine the expression
levels ofmiRNAs.miR-140was employed as a positive
control for chondrogenic differentiation [64]. Chon-
drogenic related miR-140-3p expression was notably
up-regulated in the encapsulated cells in TGF-β1
alginate-FN chondrobags (61.8-fold change forHACs
and 1.7-fold change for SSCs) (figures 6(A) and (D))
and TGF-β3 alginate-FN chondrobags (81.2-fold
change for HACs and 3.4-fold change for SSCs)
(figures 6(A) and (D)). miR-140 is an important
modulator of cartilage homeostasis and implicated
in OA. Critically, miR-140 is almost uniquely and
abundantly expressed in chondrocytes [65] and, in
addition, plays an important role in bone develop-
ment, at least in part by controlling proliferation.
Miyaki and collaborators reported that throughout
chondrogenesis,miR-140 expression levels increase in
differentiated human MSCs in comparison to undif-
ferentiated MSC populations together with expres-
sion of COL2A1, ACAN and SOX9. These finding
indicatemiR-140 is amarker and potentialmodulator
of chondrogenesis [66].
In contrast, miR-146b expression was signific-
antly down-regulated in cells encapsulated in TGF-
β1 alginate-FN chondrobags (0.8-fold change for
HACs and 0.1-fold change for SSCs) (figures 6(B)
and (E)) and in TGF-β3 alginate-FN chondrobags
(0.5-fold change for HACs and 0.2-fold change for
SSCs) (figures 6(B) and (E)). Compared to chon-
drobags cultured in basal media, miR-146b was
down-regulated during chondrogenic differentiation
of human bone marrow derived SSCs. Furthermore,
we have previously shown that miR-146b serves as
a negative modulator of chondrogenesis, with an
important role in the regulation of SOX5 expression
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Figure 6.MicroRNA profiling in HACs and SSCs cultured within chondrobags. miRNA expression in primary human articular
chondrocytes (HACs) (A-C) and primary human skeletal stem cells (SSCs) (D-F) cultured in the presence of TGF-β1 or TGF-β3
for up to 28 d relative to untreated control. Differential expression of A-D: miR-140, B-E: miR-146b, C-F: miR-138, analysed by
TaqMan qPCR. Values represent mean± SD of duplicate determinations per sample. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,
one-way ANOVA.
Figure 7. Stained encapsulated human articular chondrocytes (HACs) in alginate-fibronectin chondrobags. Alcian Blue/Sirius
Red (top row) and Safranin O/Fast Green-stained (bottom row) histological sections of chondrocytes-laden chondrobags (5 µm
sections). Histological appearance of chondrobags following basal culture for day 0 (A) and day 28 cultured in the presence of
TGF-β1 (B) and day 28 cultured in the presence of TGF-β3 (C). All images accompanied with larger magnification (right
images, #). Arrows are pointing to darker Alcian Blue staining as compared to the background lighter blue stain.
during the chondrogenic differentiation of human
bone marrow derived SSCs [67].
miR-138 expression was observed to be notably
up-regulated in HACs encapsulated in TGF-β3
alginate-FN chondrobags (1.4-fold change) but
not with TGF-β1 (0.95-fold change) (figure 6(C)).
miR-138 expression in SSCs was significantly up-
regulated under both conditions: 3.3-fold change
with TGF-β1 and 4.8-fold change with TGF-β3
(figure 6(F)). These results demonstrate the com-
mitment of HACs and SSCs following culture for
28 d in the chondrobags towards the chondrogenic
lineage. The overexpression of miR-138 has been
shown to inhibit osteoblast differentiation hMSCs
in vitro. miR-138 inhibition serves as an antimiR-
138 for promoting expression of osteoblast-specific
genes as well as the activity of ALP and matrix
mineralization [68].
3.6. Histological analysis of collagen formation in
chondrobags
Chondrobags encapsulating HACs cultured in vitro
for 28 d in the presence of TGF-β1 or TGF-β3
indicated enhanced cell proliferation evidenced by
increased collagen deposits with faint Sirius Red
staining compared to control (figure 7). This res-
ult correlated with the observation of growth and
proliferation observed in figure 3 as well as gene
expression results for proliferation and cell cycle
markers in figures 5(F))–(J)). In contrast, intense
Alcian Blue stating (but not Sirius Red staining)
was observed in the matrix of chondrobags cul-
tured in the presence of TGF-β3 (figure 7(C))
as compared to TGF-β1 (figure 7(B)) indicating
the formation of ECM (arrow). The comparatively
intensive Alcian Blue staining of cartilage matrix and
proteoglycans in chondrobags cultured in presence
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of TGF-β3 correlated with the observed gene expres-
sion studies of collagen II (COL2A1, figure 5(B))
and collagen X (COL10A1, figure 5(D)) from sim-
ilarly treated samples. Safranin-O stains polyanions
in alginate [69], thus, the formation of new cartil-
age in the chondrobags can be difficult to determ-
ine. Nevertheless, the distribution of nuclei within
the chondrobags can be clearly observed (figure 7).
The lack of fast green staining observed con-
firmed the absence of bone formation within these
sections.
4. Conclusion
The current findings demonstrate that engineered
TGF-β1 alginate-FN chondrobags provide an appro-
priate biomimetic environment for the formation
of hyaline cartilage in vitro. We demonstrate that
TGF-β1 bound to FN and presented from a solid
phase, facilitates and enhances chondrogenic differ-
entiation. Importantly, TGF-β1 loaded chondrobags
promote chondrogenesis without the formation of
hypertrophic chondrocytes. This cue-integrated-3D
biomaterial platform, demonstrated increased prolif-
eration, enhanced cell viability, chondrogenic differ-
entiation of SSCs in situ and phenotype maintenance
for HACs. The current studies illustrate the poten-
tial applications for a TGF-β1 alginate-FN chon-
drobags platform as a workable 3D bioprinting and
culture system for cartilage tissue regeneration with
therapeutic applications therein.
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